CNN Interviews Moores Member for Precision Oncology AI Model
|
Moores Member Ludmil Alexandrov, PhD and his team were featured on CNN for their deep HRD AI model, which will advance precision oncology and bring hope to patients. Learn More>>
|
Curebound Wins 2024 Pantheon Award from California Life Sciences
|
With several Moores Members having received Curebound Equity Grants, Moores is pleased to see this recognition of Curebound’s efforts in advancing cancer care for underserved communities and addressing healthcare disparities.
|
Moores-Affiliated Lab Earns National Recognition for Ovarian Cancer Research
|
Sofia Howe, a joint doctoral student at UC San Diego and San Diego State University (SDSU), who conducts research in the lab of Moores Member Carrie House, PhD at SDSU, was recognized at the SACNAS NDiSTEM conference for her poster presentation “The Role of Obese Preadipocytes in the Ovarian Cancer Tumor Microenvironment,” which was one of five graduate poster award winners. Congratulations to Sofia and Dr. House. Read more>>
|
|
|
Improving Equitable Access to Mandated Fertility Preservation Coverage in California: A Symposium
|
Moores is collaborating with the California Breast Cancer Research Program, the Alliance for Fertility Preservation, and UC San Diego’s Herbert Wertheim School of Public Health and Human Longevity Science to facilitate this symposium. Learn more and register>>
|
Salk Institute Nobel Lecture Series: 2025 Renato Dulbecco Lecture
|
On Tuesday, January 28, 2025 at 10:00 a.m. in the Conrad T. Prebys Auditorium, Matthew Vander Heiden, MD, PhD, Director of the Koch Institute for Integrative Cancer Research at MIT will present “Influence of Metabolism on Cancer Progression.” Learn more>>
|
|
|
The Researcher Spotlight is designed to help you connect with fellow researchers, gain insights into their diverse projects, and discover the paths that led them to their current roles. Uncover a personal touch to their professional achievements, showcasing the varied perspectives within our cancer research community.
|
Andrew M. Lowy, MD is a surgical oncologist with expertise in treating cancers of the pancreas and GI tract. Dr. Lowy is recognized worldwide for his expertise in pancreatic cancer surgery and in the management of complex gastrointestinal cancers. He is also known for investigating novel cancer treatments, including heated intraperitoneal chemotherapy (HIPEC), to treat advanced abdominal cancers.
|
|
|
| Therapy for stage IV non-small cell lung cancer with driver alterations: ASCO Living Guideline, Version 2024.2 |
Journal of Clinical Oncology
|
Lyudmila Bazhenova, MD (Solid Tumor Therapeutics)
|
|
|
|
CRISPR screens unveil nutrient-dependent lysosomal and mitochondrial nodes impacting intestinal tissue-resident memory CD8+ T cell formation
|
Miguel Reina-Campos, PhD (Cancer Biology and Signaling) and Ananda W. Goldrath, PhD (Hematologic Malignancies)
|
|
|
| Prevalence of steatotic liver disease, advanced fibrosis, and cirrhosis among community-dwelling overweight and obese individuals in the USA
|
Bernd G. Schnabl, MD (Cancer Biology and Signaling), Claude B. Sirlin, MD (Solid Tumor Therapeutics), and Rohit Loomba, MD (Cancer Control)
|
|
|
CLINICAL TRIALS OFFICE (CTO)
|
R3767-ONC-2208: A Phase II Peri-Operative Trial of Fianlimab and Cemiplimab Compared with Pembrolizumab in Patients with Resectable Stage III and IV Melanoma
PI: Gregory Daniels, MD, PhD
NCT: NCT06190951
MK-1026-011: A Phase III, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigators Choice of Ibrutinib or Acalabrutinib) in Participants with Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE011)
PI: Thomas Kipps, MD, PhD
NCT: NCT06136559
DCISionRT Registry 20172841: A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
PI: Dominique Rash, MD
NCT: NCT03448926
BEFORE: Bladder Full OR Empty for Pelvic Radiation Therapy (BEFORE)
PI: Tyler Seibert, MD, PhD
NCT: NCT06651697
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE)
|
Cancer Prevention and Screening at the Annual Adelante Promotores Conference
|
COE Coordinator Maritza Gomez, in partnership with Mateo Banegas, PhD, Co-Director, UC San Diego CHEER, presented a bilingual session that highlighted the essential role of Promotores and community health workers in providing education on cancer prevention and screenings in their communities.
|
Cancer Screening Guidelines at the VA Great American Smokeout Fair
|
COE liaisons shared information at the fair on tobacco, programs that help with smoking cessation, and cancer screening guidelines, which was especially helpful for military veterans who attended and may be experiencing cancer.
|
LGBTQIA Needs Assessment in Hillcrest
|
COE continues to conduct the LGBTQIA Needs Assessment. COE Liaison Krzel Manansala-Tan has distributed surveys in Hillcrest with VIDA to qualified respondents. Contact COE if you are interested in helping distribute the survey.
|
|
|
|
